跳至主要内容
临床试验/NL-OMON48319
NL-OMON48319已完成不适用

Technical Study: ACCU-CHEK Inform 3 (ACI 3) Pilot Study CIM RD003651 - ACI 3 Pilot Study

Roche Diagnostics GmbH0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Signed informed consent (before admittance to the ICU after scheduled
  • operation).
  • Diabetic and non-diabetic

排除标准

  • Minor (< 18 year)

研究者

相似试验

进行中(未招募)
1 期
A study to assess the safety and efficacy of rVA576 in patients with Paroxysmal Nocturnal Haemoglobinuria (PNH)Paroxysmal Nocturnal Haemoglobinuria (PNH)MedDRA version: 21.1Level: PTClassification code 10034042Term: Paroxysmal nocturnal haemoglobinuriaSystem Organ Class: 10038359 - Renal and urinary disorders
EUCTR2017-003847-39-LTAkari Therapeutics Plc.30
已完成
3 期
CAPSTONE: Phase III Confirmatory Assessment Protocol: rVA576 Safety and Efficacy in Three-Part, Two-Arm, Randomised Open Label Evaluation in patients with Paroxysmal Nocturnal Haemoglobinuria (PNH)Paroxysmal Nocturnal Haemoglobinuria (PNH)
SLCTR/2018/033Wynne Weston-Davies
进行中(未招募)
1 期
AFX01-13: Estudio en fase III, aleatorizado, con control activo, de etiqueta abierta y multicéntrico para evaluar la seguridad y eficacia de la inyección de AF37702 para la corrección de la anemia en pacientes con insuficiencia renal crónica (IRC), no dializados y no tratados con agentes estimuladores de la eritropoyesis (AEE)AFX01-13: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of AF37702 Injection for the Correction of Anemia in Patients with Chronic Renal Failure (CRF) not on Dialysis and not on Erythropoiesis Stimulating Agent (ESA) Treatment - PEARL 2Anemia en pacientes con insuficiencia renal crónica (IRC), no dializados y no tratados con agentes estimuladores de la eritropoyesis (AEE)Anaemia in Patients with Chronic Renal Failure (CRF) not on Dialysis and not on Erythropoiesis Stimulating Agent (ESA) TreatmentMedDRA version: 9.1Level: PTClassification code 10058116Term: Nephrogenic anaemia
EUCTR2007-004146-32-ESAffymax Inc.450
进行中(未招募)
1 期
Ensayo de fase III para evaluar la función de letrozol continuo vs. letrozol intermitente tras 4 a 6 años de terapia endocrina adyuvante previa en mujeres posmenopáusicas con cáncer de mama temprano con receptores hormonales positivos y ganglios positivos. - SOLE
EUCTR2007-001370-88-ESInternational Breast Cancer Study Group (IBCSG)4,800
尚未招募
Unknown
Developing, implementing, and evaluating the 3C Program for residential respite care seekers and their carersFrailtyCognitive ImpairmentCarer well-beingPublic Health - Health service research
ACTRN12624000246583ational Ageing Research Institute270